Labeling Strategies of Peptides with 18F for Positron Emission Tomography

Autor: Olberg De, Hjelstuen Ok

Publikováno v: Current Topics in Medicinal Chemistry. 10:1669-1679

A variety of peptides labeled with the positron emitting radionuclide fluorine-18 have shown promise as tracers for use in positron emission tomography (PET) for the detection of malignancies. Peptides can be produced with a formidable versatility al

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2249962fbc1349a38168ad3bc3f70f65
https://doi.org/10.2174/156802610793176747

A new automated and putatively versatile synthesis of the PSMA-ligand derivative [ ¹⁸ F]DCFPyL using the FASTlab ^TM synthesizer.

Autor: Hoareau R; Universitetssjukhuset Örebro, Örebro, Sweden., Bach-Gansmo T; Oslo University Hospital, Oslo, Norway., Cumming P; School of Psychology and Counselling, Queensland University of Technology, Brisbane, Australia.; Institute of Nuclear Medicine, Inelspital, University of Bern, Bern, Switzerland., Olberg DE; Norsk Medisinsk Syklotronsenter AS, Postboks 4950, 0424, Nydalen, Oslo, Norway. dag.erlend.olberg@syklotronsenteret.no.; School of Pharmacy, University of Oslo, Oslo, Norway. dag.erlend.olberg@syklotronsenteret.no.

Publikováno v: EJNMMI radiopharmacy and chemistry [EJNMMI Radiopharm Chem] 2022 May 04; Vol. 7 (1), pp. 10. Date of Electronic Publication: 2022 May 04.

Fluorine-18-Labeled Antibody Ligands for PET Imaging of Amyloid-β in Brain.

Autor: Syvänen S; Department of Public Health and Caring Sciences, Rudbeck Laboratory, Uppsala University, Uppsala 751 85, Sweden., Fang XT; Department of Public Health and Caring Sciences, Rudbeck Laboratory, Uppsala University, Uppsala 751 85, Sweden.; Department of Radiology and Biomedical Imaging, Yale University, Yale PET Center, New Haven 06520, Connecticut United States., Faresjö R; Department of Public Health and Caring Sciences, Rudbeck Laboratory, Uppsala University, Uppsala 751 85, Sweden., Rokka J; Department of Public Health and Caring Sciences, Rudbeck Laboratory, Uppsala University, Uppsala 751 85, Sweden., Lannfelt L; Department of Public Health and Caring Sciences, Rudbeck Laboratory, Uppsala University, Uppsala 751 85, Sweden.; BioArctic AB, Stockholm 112 51, Sweden., Olberg DE; Norsk medisinsk syklotronsenter AS, Oslo Postboks 4950, Norway.; Department of Pharmacy, University of Oslo, Oslo 0424, Norway., Eriksson J; Department of Medicinal Chemistry, Division of Organic Pharmaceutical Chemistry, Uppsala University, Uppsala 751 23, Sweden.; PET Centre, Uppsala University Hospital, Uppsala 751 85, Sweden., Sehlin D; Department of Public Health and Caring Sciences, Rudbeck Laboratory, Uppsala University, Uppsala 751 85, Sweden.

Publikováno v: ACS chemical neuroscience [ACS Chem Neurosci] 2020 Dec 16; Vol. 11 (24), pp. 4460-4468. Date of Electronic Publication: 2020 Nov 25.

A Survey of Molecular Imaging of Opioid Receptors.

Autor: Cumming P; Department of Nuclear Medicine, University of Bern, Inselspital, Freiburgstraße 18, 3010 Bern, Switzerland.; School of Psychology and Counselling and IHBI, Queensland University of Technology, QLD 4059, Brisbane, Australia., Marton J; ABX Advanced Biochemical Compounds, Biomedizinische Forschungsreagenzien GmbH, Heinrich-Glaeser-Strasse 10-14, D-1454 Radeberg, Germany., Lilius TO; Center for Translational Neuromedicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen N, Denmark., Olberg DE; School of Pharmacy, University of Oslo, Norwegian Medical Cyclotron Centre, N-0372 Oslo, Norway and Norwegian Medical Cyclotron Centre Ltd., Sognsvannsveien 20, N-0372 Oslo, Norway., Rominger A; Department of Nuclear Medicine, University of Bern, Inselspital, Freiburgstraße 18, 3010 Bern, Switzerland.

Publikováno v: Molecules (Basel, Switzerland) [Molecules] 2019 Nov 19; Vol. 24 (22). Date of Electronic Publication: 2019 Nov 19.

Improved Drug Delivery to Brain Metastases by Peptide-Mediated Permeabilization of the Blood-Brain Barrier.

Autor: Aasen SN; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.; Department of Biomedicine, Kristian Gerhard Jebsen Brain Tumour Research Centre, University of Bergen, Bergen, Norway., Espedal H; Department of Biomedicine, Kristian Gerhard Jebsen Brain Tumour Research Centre, University of Bergen, Bergen, Norway.; Molecular Imaging Center, Department of Biomedicine, University of Bergen, Bergen, Norway., Holte CF; Department of Biomedicine, Kristian Gerhard Jebsen Brain Tumour Research Centre, University of Bergen, Bergen, Norway., Keunen O; Department of Oncology, Luxembourg Institute of Health, Luxembourg, Luxembourg., Karlsen TV; Department of Biomedicine, University of Bergen, Bergen, Norway., Tenstad O; Department of Biomedicine, University of Bergen, Bergen, Norway., Maherally Z; Brain Tumour Research Centre, Institute of Biomedical and Biomolecular Sciences, University of Portsmouth, Portsmouth, United Kingdom., Miletic H; Department of Biomedicine, Kristian Gerhard Jebsen Brain Tumour Research Centre, University of Bergen, Bergen, Norway.; Department of Pathology, Haukeland University Hospital, Bergen, Norway., Hoang T; Department of Biomedicine, Kristian Gerhard Jebsen Brain Tumour Research Centre, University of Bergen, Bergen, Norway., Eikeland AV; Department of Radiology, Haukeland University Hospital, Bergen, Norway., Baghirov H; Department of Physics, Norwegian University of Science and Technology, Trondheim, Norway., Olberg DE; Department of Pharmaceutical Chemistry, University of Oslo, Oslo, Norway.; Norwegian Cyclotron Center, Oslo University Hospital, Oslo, Norway., Pilkington GJ; Brain Tumour Research Centre, Institute of Biomedical and Biomolecular Sciences, University of Portsmouth, Portsmouth, United Kingdom., Sarkar G; Division of Experimental Pathology, Mayo Clinic, Rochester, Minnesota., Jenkins RB; Division of Experimental Pathology, Mayo Clinic, Rochester, Minnesota., Sundstrøm T; Department of Biomedicine, Kristian Gerhard Jebsen Brain Tumour Research Centre, University of Bergen, Bergen, Norway.; Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Medicine, University of Bergen, Bergen, Norway., Bjerkvig R; Department of Biomedicine, Kristian Gerhard Jebsen Brain Tumour Research Centre, University of Bergen, Bergen, Norway.; Department of Oncology, Luxembourg Institute of Health, Luxembourg, Luxembourg., Thorsen F; Department of Biomedicine, Kristian Gerhard Jebsen Brain Tumour Research Centre, University of Bergen, Bergen, Norway. Frits.Thorsen@uib.no.; Molecular Imaging Center, Department of Biomedicine, University of Bergen, Bergen, Norway.

Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2019 Nov; Vol. 18 (11), pp. 2171-2181. Date of Electronic Publication: 2019 Aug 29.